Neurones (XPAR:NRO) Margin of Safety % (DCF Earnings Based): 5.39% (As of Jun. 25, 2026)


XPAR:NRO Neurones XPAR:NRO
96 GF Score
Price €35.10
GF Value €50.23
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Neurones Margin of Safety % (DCF Earnings Based)?

Neurones XPAR:NRO -0.28% 96 Margin of Safety % (DCF Earnings Based) is 5.39% as of Jun. 25, 2026. GuruFocus rates XPAR:NRO with a GF Score™ of 96/100 and a GF Value™ of €50.23 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2026-06-25), Neurones's Predictability Rank is 4.5-Stars. Neurones's intrinsic value calculated from the Discounted Earnings model is €37.10 and current share price is €35.10. Consequently,

Neurones's Margin of Safety % (DCF Earnings Based) using Discounted Earnings model is 5.39%.

XPAR:NRO vs IBM, ACN, FISV: Margin of Safety % (DCF Earnings Based) Comparison

For the Information Technology Services subindustry, Neurones's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neurones Margin of Safety % (DCF Earnings Based) vs Software Industry

For the Software industry and Technology sector, Neurones's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Neurones's Margin of Safety % (DCF Earnings Based) falls into.


XPAR:NRO
96GF Score
Neurones XPAR:NRO
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Neurones Margin of Safety % (DCF Earnings Based) Calculation

Neurones's Margin of Safety % (DCF Earnings Based) for today is calculated as

Margin of Safety % (DCF Earnings Based)=(Intrinsic Value: DCF (Earnings Based)-Current Price)/Intrinsic Value: DCF (Earnings Based)
=(37.10-35.10)/37.10
=5.39 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted Earnings model with default parameters. The calculation method is the same as Discounted Cash Flow model except earnings are used in the calculation instead of free cash flow.

What does a Margin of Safety % (DCF Earnings Based) of 5.39% mean?
Neurones (XPAR:NRO) has a Margin of Safety % (DCF Earnings Based) of 5.39% as of Jun. 25, 2026. Margin of Safety % (DCF Earnings Based) is the percent difference between the current price and the intrinsic DCF Earnings price. View historical data on Neurones.
Is Neurones' Margin of Safety % (DCF Earnings Based) too high?
Neurones' current Margin of Safety % (DCF Earnings Based) is 5.39%. Overall, Neurones has a GF Score™ of 96/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Neurones' Margin of Safety % (DCF Earnings Based) compare to IBM and ACN?
Neurones' Margin of Safety % (DCF Earnings Based) of 5.39% can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Margin of Safety % (DCF Earnings Based) for a Software company?
A good Margin of Safety % (DCF Earnings Based) depends on the Software industry context. However, Margin of Safety % (DCF Earnings Based) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Margin of Safety % (DCF Earnings Based) mean?
A high Margin of Safety % (DCF Earnings Based) can signal that a stock is expensive relative to its fundamentals. Margin of Safety % (DCF Earnings Based) is the percent difference between the current price and the intrinsic DCF Earnings price. View historical data on Neurones. Neurones's current Margin of Safety % (DCF Earnings Based) is 5.39%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neurones stock overvalued right now?
Based on GuruFocus' analysis, Neurones (XPAR:NRO) is currently considered Significantly Undervalued. The stock's GF Value™ is €50.23, compared to a current price of €35.10 — trading 30.1% below its estimated fair value. The current Margin of Safety % (DCF Earnings Based) is 5.39%. Neurones' overall GF Score™ is 96/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Margin of Safety % (DCF Earnings Based) calculated?
Margin of Safety % (DCF Earnings Based) is calculated from a company's financial statements. For Neurones (XPAR:NRO), the current Margin of Safety % (DCF Earnings Based) is 5.39% as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Neurones (XPAR:NRO) Overvalued in 2026?

Based on GuruFocus' analysis, Neurones stock appears to be undervalued. The current stock price of €35.10 is trading 30.1% below its estimated GF Value™ of €50.23. GuruFocus considers Neurones to be Significantly Undervalued.

Key valuation signals for XPAR:NRO:

  • Margin of Safety % (DCF Earnings Based): 5.39%
  • GF Value™: €50.23 vs. price of €35.10 (30.1% below fair value)
  • GF Score™: 96/100 with 3 warning signs

No single metric tells the full story. See the XPAR:NRO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Neurones Business Description

Other Exchanges 0GX2:UKNE9:Germany
Address 205 Avenue Georges Clemenceau, Immeuble Le Clemenceau 1 Building, Nanterre, FRA, 92024
Neurones is active in Consulting and Digital Services, with activities including Digital Transformation, Overall Offer, Infrastructure Hub, Applications Hub, Consulting Division, Managed Services, and Service Centers. It also conducts IT development, pre-sales activities, management of fixed-price projects, technical assistance, infrastructure operations, and cybersecurity, and provides an internal platform for multi-LLM assistants, including Microsoft Copilot, ChatGPT, Gemini, Claude, and Mistral. Its segments are Infrastructure Services, Application Services, and Consulting. Infrastructure Services generates the majority of revenue and includes Cloud, Infrastructure Management, DevOps, Cybersecurity, User Support, IT Service Management, Information System Governance, and Automation.
96GF Score

Get the complete analysis for XPAR:NRO

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€35.10
Price
€50.23
GF Value